Invasive pneumococcal disease (IPD) is a vaccinepreventable disease that can manifest as severe illness, such as septicemia or meningitis. IPD surveillance systems monitor morbidity, mortality, and the impact of pneumococcal vaccination; therefore, accurate surveillance is important to monitor changes in IPD epidemiology. 1 IPD surveillance data were also used to monitor vaccine effectiveness during and after licensure of the 7-valent pneumococcal conjugate vaccine in 2000 and the 13-valent pneumococcal conjugate vaccine in 2010.
In New Mexico, IPD became a reportable condition in 1998. 2 Health-care providers must report IPD to the New Mexico Department of Health (NMDOH) within 24 hours of identification. In 2004, NMDOH began participating in the national emerging infections program Active Bacterial Core Surveillance (ABCs), a laboratory-and population-based surveillance system for bacterial diseases, including IPD, of public health significance. For more than 10 years, the ABCs program in New Mexico has conducted regular audits of clinical and reference laboratory records to ensure reporting completeness. IPD reporting in New Mexico stabilized after ABCs was initiated in 2004 ( Figure 1 ). During 2008-2012, 1,642 IPD illnesses were identified in New Mexico, and the overall rate of IPD was 16.0 per 100,000 population. 3 An estimated 196,200 IPD cases were identified in the United States during this time, with a rate of 12.7 per 100,000 population. 4 In addition to its participation in the ABCs program, NMDOH collects data on hospitalizations, including IPD hospitalizations, through the New Mexico Hospital Inpatient Discharge Database (HIDD). This surveillance system was established in 1989 and was originally administered by the New Mexico Health Policy Commission. From 1989 until 2010, the Health Policy Commission analyzed and disseminated information on hospitalizations for use by public and private entities in health planning and policy development. In 2011, HIDD maintenance and reporting became the exclusive responsibility of NMDOH.
Data collected through surveillance systems should be evaluated regularly to improve data quality and identify methods to improve surveillance. Hospital discharge data have been used in surveillance system assessments to help identify cases of diseases with high b Active surveillance refers to a system employing staff members to regularly contact heath-care providers and laboratories to seek information about invasive pneumococcal disease.
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Year hospitalization rates. 5, 6 Active surveillance systems for IPD, such as the ABCs program, can provide information on quality and completeness of HIDD data. No study has yet compared IPD data from the HIDD and IPD data from the ABCs program in New Mexico. We evaluated reporting completeness for IPD in New Mexico by comparing HIDD hospital discharge data and ABCs surveillance data, and we assessed the quality of HIDD data by reviewing laboratory reports.
MATERIALS AND METHODS
In the ABCs program, cases of IPD are defined as Streptococcus pneumoniae (S. pneumoniae) isolated from a normally sterile body site. ABCs program staff members identify potential IPD cases in New Mexico through the National Electronic Disease Surveillance System and laboratory audits. For each case, a medical record review is performed to extract demographic and medical information and to ensure that bacterial isolates are sent to the Centers for Disease Control and Prevention and other reference laboratories for additional laboratory evaluation.
General and specialty hospitals in New Mexico are required to submit data to the NMDOH through the HIDD. Federal facilities are not required to report data to the NMDOH; therefore, Indian Health Service, military, and Veteran Affairs hospitals do not report these data. The purpose of data collection through the HIDD is to identify, analyze, and disseminate health information generated by hospitals. Information includes patient identifiers, demographics, diagnoses and procedures, total costs, and individual revenue codes (added in 2013). Diagnoses and procedures specified in the database are coded by using the International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM). 7 Hospitals submit information on discharges quarterly. Final corrected versions are submitted annually by hospitals after hospital review.
We defined a potential IPD case in the HIDD as a case assigned a specific or nonspecific ICD-9-CM code for IPD and for which a New Mexico resident was hospitalized from January 1, 2007, through December 31, 2009. Specific codes were for meningitis (320.1) and septicemia (038.2) resulting from S. pneumoniae infection. Nonspecific codes were for pneumonia (481), streptococcal meningitis (320.2), and S. pneumoniae as the cause of bacterial infection, classified elsewhere, of unspecified body site (041.2). We defined an inpatient discharge as a departure from a hospital by a patient admitted to an inpatient ward for at least one night. A patient admitted to Hospital A for at least one night and then transferred to Hospital B for at least one night would have two discharge records in HIDD: the initial discharge from Hospital A and a second discharge from Hospital B.
HIDD records (n51,300) and ABCs records (n51,191) were de-duplicated before they were matched ( Figure 2 ). We examined HIDD records that had a discharge listed as a transfer to determine if multiple records were generated for these consecutive events. If the admission and discharge dates of the records corresponded, only the record for the first discharge event was retained; otherwise, all records were retained as potentially unique discharges. The initial data linkage process used an exact match on the date of birth, treatment hospital, and date of hospital admission to merge records from the ABCs program and the HIDD. For records that did not initially match, we performed a second round of data linkage by using partial first name match, date of birth, and treatment hospital. Results of this linkage were manually reviewed to identify and remove matches with incompatible dates for hospital admission and laboratory specimen collection. We performed data linkage using SAS ® version 9.3. 8 We collected microbiology laboratory reports for HIDD cases that were not reported in the ABCs data. We categorized laboratory data according to pathogen. We then determined whether the specimen site was sterile or nonsterile by using the ABCs definition of a sterile body site (e.g., blood, cerebrospinal fluid, joint fluid). We combined laboratory data with the electronic HIDD data for analysis. We extracted a list of potential IPD cases in HIDD records that indicated a positive result of S. pneumoniae isolated from a sterile body site and that were not matched in the ABCs data. We recalculated the rate of IPD in New Mexico after adding these cases to the ABCs data on the basis of a summation population estimate of 6,039,184 in 2007-2009.
We also reviewed the location of hospitalization for the cases found only in the ABCs database to investigate potential reasons that the HIDD did not capture data on these hospitalizations. We examined cases found in HIDD records and not in ABCs records to determine why these cases might have been missed.
We used the Chandra Sekar-Deming capturerecapture method to estimate the total number of IPD cases in New Mexico. 9, 10 We calculated sensitivity, specificity, positive predictive value, and negative predictive value for specific and nonspecific ICD-9-CM codes in the HIDD. This calculation excluded (1) records from federal and out-of-state facilities because they are not required to report data to the HIDD and (2) records obtained through the Office of the Medical Investigator in the absence of an antecedent hospitalization. Sensitivity and specificity could not be calculated for the ICD-9-CM codes of ABCs cases because the surveillance system does not collect ICD-9-CM codes.
RESULTS
We found 527 records of IPD in New Mexico in both HIDD and ABCs data. Of the 1,395 unmatched records, 663 were from the ABCs database and 732 were from the HIDD (Figure 2 ). Of the 732 unmatched HIDD records, 15 records did not have laboratory reports, and we could not definitively determine case status. Of the 717 HIDD records that had laboratory reports, 707 did not meet ABCs's case definition of IPD and were therefore determined to be potentially miscoded; 291 (41%) reports indicated that S. pneumoniae had been isolated from a nonsterile site, and 416 (59%) reports indicated that S. pneumoniae had not been isolated ( Table 1 ). Ten of the 717 HIDD records had laboratory reports indicating isolation of S. pneumoniae from a sterile body site and were not matched in the ABCs database. These 10 HIDD records, which met ABCs' case definition of IPD, were considered to have been missed by the ABCs program. These 10 cases were missed by the ABCs program for several reasons: two cases were not listed in the handwritten laboratory test log and, therefore, were not captured on audit; two cases were missed because of changes in laboratory staffing and a failure to transfer knowledge to new staff members at the laboratory; two cases' cultures were not coded as invasive and were, therefore, not included in the automated electronic report; one case was erroneously omitted from a laboratory-generated audit list; and three cases were missed for an undetermined reason. After adding the 10 cases to the ABCs database, the number of cases in the database increased from 1,190 to 1,200, and the rate of IPD in New Mexico increased from 19.7 cases per 100,000 population to 19.9 cases per 100,000 population. After post hoc laboratory review, HIDD data alone (537 IPD cases) yielded a rate of 8.9 cases per 100,000 population.
Of the 663 cases found only in the ABCs database, we examined the records available for 660 cases (records were not available for three cases). Of these 660 cases, 130 (20%) were hospitalizations at federal facilities (Indian Health Service or Veterans Administration), 36 (5%) were hospitalizations at out-of-state facilities, and two (,1%) were cases captured through record review at the Office of the Medical Investigator and determined not to be hospitalizations. Ninety-one cases found only in the ABCs database were not hospitalizations. However, 401 cases (60%) found only in the ABCs database were hospitalizations at facilities in New Mexico that report to HIDD. Chandra Sekar-Deming capture-recapture calculation yielded an estimated 556 IPD cases missed by both the HIDD and the ABCs program. Using ABCs data as the gold standard, HIDD ICD-9-CM codes had an estimated sensitivity of 57% and a specificity of 43%; positive predictive value was 42% and negative predictive value was 58%. Sensitivity, specificity, positive predictive value, and negative predictive value differed for specific and nonspecific HIDD ICD-9-CM codes ( Table 2) .
DISCUSSION
Overall, the addition of IPD cases to the ABCs program found through the HIDD and post hoc laboratory report review were of minimal benefit to active surveillance of IPD in New Mexico. Data on cases missed by the ABCs program, found through HIDD linkage, were useful in detecting potential miscoding of invasive and noninvasive cases at laboratories performing pneumococcal testing, but did not significantly affect IPD rates in the state. After this analysis, audit methods were improved at one laboratory to make identification Of the 717 HIDD records that had laboratory reports, 707 did not meet the ABCs case definition of IPD and were therefore determined to be potentially miscoded; 10 met the IPD case definition. f Nonsterile sites included, but were not limited to, bronchial-alveolar lavage, endotracheal tubes, sputum, trans-tracheal wash, and urine.
ICD-9-CM 5 International Classification of Diseases, Ninth Revision, Clinical Modification of cases more manageable by the facility. Periodic review of laboratories' audit and coding procedures are performed by ABCs personnel to mitigate some of the reasons cases were initially missed by the ABCs program. However, the results of this analysis suggest that facilities undergoing changes in laboratory and infection prevention staffing, hospitals with handwritten laboratory test logs, and certain coding procedures for generating automated electronic laboratory reports might need additional attention to ensure that protocols and procedures are developed and followed to identify IPD cases in a variety of settings with access to different levels of technology. The specific ICD-9-CM codes used to identify potential IPD cases in HIDD records had moderate sensitivity and high specificity. The nonspecific codes had moderate sensitivity and low specificity. Thus, ICD-9-CM codes in the HIDD were not sensitive enough to reliably identify IPD cases, and the amount of effort expended to gather laboratory results to verify coding was too great to be routinely useful in supplementing ABCs data. However, in a state that does not have active surveillance, ICD-9-CM codes could help to limit the number of records identified that do not meet the IPD case definition (i.e., false positives) and identify additional cases. Using nonspecific codes, such as those included in this analysis, was not useful in identifying IPD cases because of the high rate of false positives.
The low sensitivity of ICD-9-CM codes for IPD can be attributable to several factors. Although incomplete and erroneous examination of medical records by hospital abstractors contributes to coding errors, research indicates that physicians are also responsible for coding errors. 6, 11, 12 Clinicians do not generally assign codes; coders assign them. However, coders rely on the diagnosis and documentation provided by clinicians. In addition, culture results might not be available to physicians or those assigning ICD-9-CM codes at the time of discharge, and the lack of results might account for some miscoding. Other factors affecting ICD code accuracy include quantity and quality of information at admission, during hospitalization, and at discharge; clinician knowledge and experience; and quality of documentation. Additional errors in coding can result from differences between electronic and written records, coder training and experience, facility quality-control and quality-assurance efforts, and unintentional and intentional coder errors. 12 Adoption of International Classification of Diseases, Tenth Revision, Clinical Modification is expected to capture data on diseases of public health significance more often than ICD-9-CM because it is more specific and more fully describes nationally reportable diseases. 13 Additionally, examination of IPD case records not identified by the HIDD is warranted. Some of these patients were not in the HIDD system because of limitations in the HIDD data (e.g., lack of data from federal and out-of-state facilities). However, 60% of cases that were in the ABCs database but not in the HIDD were hospitalized at facilities in New Mexico that report to the HIDD. These records might have been found elsewhere in the HIDD database, but they did not indicate a specific or a nonspecific ICD-9-CM code for S. pneumoniae. Furthermore, the ABCs database included patients with pneumococcal septic arthritis and peritonitis; the ICD-9-CM codes used to request data from the HIDD did not include codes 711.07 (pneumococcal arthritis, plus other pyogenic arthritis), 567.1 (pneumococcal peritonitis), or 567.23 (spontaneous bacterial peritonitis); use of these codes might have helped identify IPD cases in the HIDD.
Most cases found only in the ABCs database were expected to be in the HIDD because of the specific and nonspecific ICD-9-CM codes used in the analysis. IPD case-ascertainment deficiencies in the HIDD should be investigated in coding studies and through periodic data linkages with other sources to ensure complete reporting.
PRACTICE IMPLICATIONS
Ascertainment of IPD cases in New Mexico through the ABCs program is mostly complete. However, states that rely exclusively on passive reporting and that have access to HIDD data might consider linking their passively reported data with pneumococcal and IPD-specific ICD-9-CM-coded HIDD data to improve IPD surveillance and case ascertainment. Review of laboratory reports and medical records is an essential component when using the HIDD, because coding alone does not ensure data accuracy. The HIDD might be more useful for augmenting surveillance systems for noninvasive diseases that result in patient hospitalization. Active surveillance continues to be the gold standard for diseases such as IPD and is not subject to the same limitations as the HIDD; however, active surveillance can be cost-prohibitive. In states where active surveillance data are available, the data are useful in validating HIDD data, quantifying missing data, and improving completeness of reporting.
